FDA Approved: OXCARBAZEPINE — Supplemental Application (Advagen Pharma Limited)

View source ↗

Summary

The FDA issued a supplemental approval for oxcarbazepine by Advagen Pharma Limited, resulting in changes to the product's labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial-onset Seizures

Drugs mentioned

• Oxcarbazepine (Oxcarbazepine)

Snippet

SUPPL AP for OXCARBAZEPINE (OXCARBAZEPINE)